Vera Therapeutics, Inc.Vera Therapeutics, Inc.Vera Therapeutics, Inc.

Vera Therapeutics, Inc.

No trades
See on Supercharts

Price target

67.800.000.00%
The 10 analysts offering 1 year price forecasts for VERA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 10 analysts giving stock ratings to VERA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


VERA EPS for the last quarter is −0.85 USD despite the estimation of −0.64 USD. In the next quarter EPS is expected to reach −0.74 USD. Track more of Vera Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Vera Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Vera Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, VERA price target is 67.80 USD with a max estimate of 107.00 USD and a min estimate of 38.00 USD. Check if this forecast comes true in a year, meanwhile watch Vera Therapeutics, Inc. stock price chart and keep track of the current situation with VERA news and stock market news.
We've gathered opinions of 10 analysts rating VERA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.